0 Commentaires
0 Parts
859 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Marketplace
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
Biologics and Biosimilars Market by 2031 – Segmentation Analysis, Trends, and Key PlayersThe biologics and biosimilars market is poised for significant growth over the next decade, driven by rising demand for advanced therapies to treat chronic, autoimmune, and life-threatening diseases. Biologics, complex medicines derived from living organisms, are increasingly preferred for their targeted therapeutic effects, while biosimilars offer highly similar alternatives at reduced costs,...0 Commentaires 0 Parts 964 Vue 0 Aperçu
-
Global Biologics Contract Development Market Key Players, Trends, Sales, Supply, Demand, Analysis and Forecast 2025-2034The market research for the global Biologics Contract Development market is an accumulation of first-hand facts and quantitative and qualitative evaluation and analysis for the forecast period (2024-2032). The report offers a comprehensive assessment of macro-economic indicators, parent market trends, and several factors influencing the market dynamics. In addition, it also...0 Commentaires 0 Parts 779 Vue 0 Aperçu
-
Next-Gen Biologics and Cell Therapies Propel Advanced Therapeutics Market ForwardDetailed Analysis of Executive Summary Advanced Therapeutics Market Size and Share Global Advanced Therapeutics market size was valued at USD 11.52 billion in 2024 and is projected to reach USD 21.90 billion by 2032, with a CAGR of 8.40% during the forecast period of 2025 to 2032. Advanced Therapeutics Market research report is a great backbone for the expansion of Advanced...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
North America Adalimumab Market Growth Outlook Supported by Biologics Demand & Autoimmune Treatment Expansion"In-Depth Study on Executive Summary North America Adalimumab Market Size and Share CAGR Value Data Bridge Market Research analyses a growth rate in the adalimumab market in the forecast period 2023-2030. The expected CAGR of adalimumab market is tend to be around 5.40 % in the mentioned forecast period. The market was valued at USD 16,879.8 million in 2022, and it would grow upto USD...0 Commentaires 0 Parts 973 Vue 0 Aperçu
-
North America Biologics Market: Dynamics, Trends, and Future Outlook (2023-2031)The North America biologics market is witnessing substantial growth driven by technological advancements, increasing prevalence of chronic diseases, and rising investments in research and development. Biologics, which include monoclonal antibodies, vaccines, recombinant proteins, and gene therapies, are transforming modern healthcare by offering targeted and highly effective treatments. The...0 Commentaires 0 Parts 25 Vue 0 Aperçu
-
Spinal Devices and Biologics Market Opportunities: Growth, Share, Value, Size, and Scope"Executive Summary Spinal Devices and Biologics Market : Data Bridge Market Research analyses that the spinal devices and biologics market which is USD 8478.94 million in 2022, is expected to reach USD 29773.40 million by 2030, at a CAGR of 17.00% during the forecast period 2023 to 2030. An international Spinal Devices and Biologics Market research report is an absolute...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Are HER2 Inhibitors Transforming Targeted Therapy in Oncology Treatment?Executive Summary HER2 Inhibitors Market: Share, Size & Strategic Insights CAGR Value The global HER2 inhibitors market size was valued at USD 11.05 billion in 2025 and is expected to reach USD 22.02 billion by 2033, at a CAGR of 9.00% during the forecast period HER2 Inhibitors Market research report works best for the systematic gathering,...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Biosimilars Market Opportunities for Pharma and Biotech CompaniesThe increasing role of biosimilars in hospital treatment protocols is another factor driving market growth. Hospitals are adopting biosimilars to manage healthcare budgets effectively. This shift is improving patient access to essential biologic therapies. The global Biosimilars Market is experiencing remarkable growth as healthcare systems increasingly adopt cost-effective alternatives...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Can Immune-Modulating Biologic Drugs Redefine Cancer Treatment Worldwide?Executive Summary Immune-Modulating Oncology Biologic Drugs Market Market Size and Share Analysis Report CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period This Immune-Modulating...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
cGMP Process Development Market to Reach USD 6.06 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global cGMP Process Development market was valued at USD 3.75 billion in 2025 and is projected to reach USD 6.06 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2032. cGMP process development represents the critical discipline of systematically designing,...0 Commentaires 0 Parts 347 Vue 0 Aperçu
-
cGMP Process Development Market to Reach USD 6.06 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global cGMP Process Development market was valued at USD 3.75 billion in 2025 and is projected to reach USD 6.06 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2032. cGMP process development represents the critical discipline of systematically designing,...0 Commentaires 0 Parts 341 Vue 0 Aperçu
-
Comprehensive Market Overview and Strategic Analysis of the Drugs of Bioengineered Protein Market 2034The Drugs of Bioengineered Protein Market report presents a detailed evaluation of the global landscape of bioengineered protein therapeutics, focusing on industry trends, segmentation, and growth trajectories that are reshaping modern healthcare. This expansive market includes a diverse range of biologic drugs such as cytokines and chemokines, peptide hormones, peptide antibiotics, monoclonal...0 Commentaires 0 Parts 596 Vue 0 Aperçu
-
How Is Fermentation Technology Revolutionizing Pharmaceutical API Production?Global Executive Summary Fermentation-Derived Pharmaceutical API Market: Size, Share, and Forecast CAGR Value The global fermentation-derived pharmaceutical API market size was valued at USD 841.50 million in 2025 and is expected to reach USD 1689.08 million by 2033, at a CAGR of 9.10% during the forecast period The complete Fermentation-Derived...0 Commentaires 0 Parts 339 Vue 0 Aperçu
-
In-Depth 2031 Forecast: Drug Development Market Growth, Innovation, and Competitive LandscapeDrug development is the pathway through which potential drug candidates are evaluated for medical use. Scientists study their pharmacological effects, dosage, and side effects. Only successful candidates proceed to commercial production. Drug Development Market In Depth Analysis The Drug Development Market is expected to register a CAGR of 9.2% from 2025 to 2031, reflecting strong...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Is the Global EPO Drugs Market Expanding With Rising Chronic Kidney Disease and Anemia Cases?Executive Summary Erythropoietin (EPO) Drugs Market Size and Share Forecast The global erythropoietin (EPO) drugs market size was valued at USD 9.12 billion in 2024 and is expected to reach USD 22.60 billion by 2032, at a CAGR of 12.00% during the forecast period The Erythropoietin (EPO) Drugs report also makes available CAGR value fluctuation...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
Plus de résultats
Commandité
Commandité
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek